Endocrine Abstracts

Background: Male hypogonadism is associated with reduction in bone mineral density (BMD). This study aimed to determine the epidemiology of low BMD in a clinic-based cohort of hypogonadal men.Methods: This was a retrospective, cross-sectional observational study of 152 patients (≥18 years with testosterone(T) ≤11 nmol/L) who were consequently reviewed in an endocrine clinic. Data was extracted from electronic patient records and included base...

Background: Male hypogonadism is commonly caused by hypothalamo-pituitary testicular disease. The effect of modifiable risk factors (obesity, alcohol, smoking, prescribed medications and recreational drugs) on secondary hypogonadism in a clinic-based cohort is unclear. The aim of this study was to ascertain the prevalence and effects of modifiable risk factors on secondary hypogonadism.Method: This was a retrospective, cross-sectional observational study...

Case History: We report the case history of a 64-year-old woman who was admitted to hospital for evaluation of unsteadiness associated with postural hypotension. There was no history of headache, visual blurring, weight loss, diarrhoea or steroid treatment. She was taking high dose medroxyprogesterone acetate (MPA) 100 mg three times per day for 5 years following diagnosis of complex hyperplasia on endometrial biopsy for postmenopausal bleeding. Her past history included ischa...